(Información remitida por la empresa firmante)
Email: Stephanie.Carrington@westwicke.comMedios:
Alexis Feinberg
Tel: +1 203-939-2225
Email: alexis.feinberg@westwicke.com
Logo — https://mma.prnewswire.com/media/1810847/promontory_logo_rgb_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/promontory-therapeutics-presenta-en-esmo-i-o-2022-datos-de-seguridad-y-eficacia-de-pt-112-301697835.html